PCMC
BSX icon

Planning Capital Management Corporation’s Boston Scientific BSX Stock Holding History

Planning Capital Management Corporation’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-97
Closed -$7.47K – 801
2024
Q2 		$7.47K Hold
97
– – 0.01% 432
2024
Q1 		$6.64K Hold
97
– – ﹤0.01% 459
2023
Q4 		$5.61K Buy
+97
New +$5.18K ﹤0.01% 471

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Planning Capital Management Corporation's BSX Position: Q3 2024 in Review

Planning Capital Management Corporation sold out of Boston Scientific (BSX) in Q3 2024, closing a stake of 97 shares — an estimated $7.47K sold.

Planning Capital Management Corporation first reported a position in BSX in Q4 2023 and held it in 3 quarters. The position peaked at $7.47K in Q2 2024. 1,396 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • Planning Capital Management Corporation reported no remaining Boston Scientific position as of Q3 2024 after selling out during the quarter.
  • Planning Capital Management Corporation sold 97 Boston Scientific shares in Q3 2024, an estimated $7.47K.
  • Planning Capital Management Corporation first reported a position in Boston Scientific in Q4 2023 and held it in 3 quarters.
  • Planning Capital Management Corporation's Boston Scientific position peaked at $7.47K in Q2 2024.
  • 1,396 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.